Connection

Jacqueline Mcginty to Corpus Striatum

This is a "connection" page, showing publications Jacqueline Mcginty has written about Corpus Striatum.
Connection Strength

6.870
  1. Cocaine self-administration causes signaling deficits in corticostriatal circuitry that are reversed by BDNF in early withdrawal. Brain Res. 2015 Dec 02; 1628(Pt A):82-7.
    View in: PubMed
    Score: 0.400
  2. D1 and D2 dopamine receptors differentially mediate the activation of phosphoproteins in the striatum of amphetamine-sensitized rats. Psychopharmacology (Berl). 2011 Apr; 214(3):653-63.
    View in: PubMed
    Score: 0.305
  3. Suppression of activity-regulated cytoskeleton-associated gene expression in the dorsal striatum attenuates extinction of cocaine-seeking. Int J Neuropsychopharmacol. 2011 Jul; 14(6):784-95.
    View in: PubMed
    Score: 0.304
  4. An intrastriatal brain-derived neurotrophic factor infusion restores striatal gene expression in Bdnf heterozygous mice. Brain Struct Funct. 2010 Aug; 215(2):97-104.
    View in: PubMed
    Score: 0.304
  5. Minocycline restores striatal tyrosine hydroxylase in GDNF heterozygous mice but not in methamphetamine-treated mice. Neurobiol Dis. 2009 Mar; 33(3):459-66.
    View in: PubMed
    Score: 0.267
  6. Relapse to cocaine-seeking increases activity-regulated gene expression differentially in the striatum and cerebral cortex of rats following short or long periods of abstinence. Brain Struct Funct. 2008 Sep; 213(1-2):215-27.
    View in: PubMed
    Score: 0.257
  7. Regulation of psychostimulant-induced signaling and gene expression in the striatum. J Neurochem. 2008 Mar; 104(6):1440-9.
    View in: PubMed
    Score: 0.251
  8. Regulator of G-protein signaling 4 interacts with metabotropic glutamate receptor subtype 5 in rat striatum: relevance to amphetamine behavioral sensitization. J Pharmacol Exp Ther. 2007 Nov; 323(2):650-7.
    View in: PubMed
    Score: 0.244
  9. BDNF heterozygous mice demonstrate age-related changes in striatal and nigral gene expression. Exp Neurol. 2006 Jun; 199(2):362-72.
    View in: PubMed
    Score: 0.220
  10. Extracellular signal-regulated mitogen-activated protein kinase inhibitors decrease amphetamine-induced behavior and neuropeptide gene expression in the striatum. Neuroscience. 2006; 138(4):1289-98.
    View in: PubMed
    Score: 0.219
  11. GABAB receptor stimulation decreases amphetamine-induced behavior and neuropeptide gene expression in the striatum. Brain Res. 2004 Apr 09; 1004(1-2):18-28.
    View in: PubMed
    Score: 0.193
  12. Local mu and delta opioid receptors regulate amphetamine-induced behavior and neuropeptide mRNA in the striatum. Neuroscience. 2003; 121(2):387-98.
    View in: PubMed
    Score: 0.177
  13. Gene expression profile from the striatum of amphetamine-treated rats: a cDNA array and in situ hybridization histochemical study. Brain Res Gene Expr Patterns. 2002 Oct; 1(3-4):193-8.
    View in: PubMed
    Score: 0.174
  14. NK-1 receptor blockade decreases amphetamine-induced behavior and neuropeptide mRNA expression in the striatum. Brain Res. 2002 Mar 22; 931(1):41-9.
    View in: PubMed
    Score: 0.168
  15. Intrastriatal GABA(A) receptor blockade does not alter dopamine D(1)/D(2) receptor interactions in the intact rat striatum. Neuroscience. 2001; 102(2):381-9.
    View in: PubMed
    Score: 0.154
  16. Delta opioid receptors regulate calcium-dependent, amphetamine-evoked glutamate levels in the rat striatum: an in vivo microdialysis study. Brain Res. 2000 Apr 10; 861(2):296-304.
    View in: PubMed
    Score: 0.147
  17. Autoradiographic evidence that intrastriatal administration of adenosine A(1) receptor antisense oligodeoxynucleotide decreases adenosine A(1) receptors in the rat striatum and cortex. Brain Res Mol Brain Res. 1999 Oct 01; 72(2):226-30.
    View in: PubMed
    Score: 0.141
  18. Advancing from the ventral striatum to the extended amygdala. Implications for neuropsychiatry and drug abuse. Introduction. Ann N Y Acad Sci. 1999 Jun 29; 877:xii-xv.
    View in: PubMed
    Score: 0.139
  19. Regulation of neurotransmitter interactions in the ventral striatum. Ann N Y Acad Sci. 1999 Jun 29; 877:129-39.
    View in: PubMed
    Score: 0.139
  20. Muscarinic receptors regulate extracellular glutamate levels in the rat striatum: an in vivo microdialysis study. J Pharmacol Exp Ther. 1998 Jul; 286(1):91-8.
    View in: PubMed
    Score: 0.130
  21. Metabotropic glutamate receptor agonist increases neuropeptide mRNA expression in rat striatum. Brain Res Mol Brain Res. 1998 Mar 01; 54(2):262-9.
    View in: PubMed
    Score: 0.127
  22. Kappa receptor activation attenuates L-trans-pyrrolidine-2,4-dicarboxylic acid-evoked glutamate levels in the striatum. J Neurochem. 1998 Feb; 70(2):626-34.
    View in: PubMed
    Score: 0.126
  23. Drugs of abuse and striatal gene expression. Adv Pharmacol. 1998; 42:1017-9.
    View in: PubMed
    Score: 0.125
  24. The muscarinic toxin 3 augments neuropeptide mRNA in rat striatum in vivo. Eur J Pharmacol. 1997 Sep 03; 334(1):43-7.
    View in: PubMed
    Score: 0.122
  25. Intrastriatal injection of a muscarinic receptor agonist and antagonist regulates striatal neuropeptide mRNA expression in normal and amphetamine-treated rats. Brain Res. 1997 Feb 14; 748(1-2):62-70.
    View in: PubMed
    Score: 0.118
  26. Muscarinic receptors regulate striatal neuropeptide gene expression in normal and amphetamine-treated rats. Neuroscience. 1996 Nov; 75(1):43-56.
    View in: PubMed
    Score: 0.115
  27. Intrastriatal injection of the metabotropic glutamate receptor antagonist MCPG attenuates acute amphetamine-stimulated neuropeptide mRNA expression in rat striatum. Neurosci Lett. 1996 Oct 25; 218(1):13-6.
    View in: PubMed
    Score: 0.115
  28. Scopolamine augments c-fos and zip/268 messenger RNA expression induced by the full D(1) dopamine receptor agonist SKF-82958 in the intact rat striatum. Neuroscience. 1996 Jun; 72(3):601-16.
    View in: PubMed
    Score: 0.112
  29. D1 and D2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine. Synapse. 1996 Feb; 22(2):114-22.
    View in: PubMed
    Score: 0.110
  30. Acute methamphetamine-induced zif/268, preprodynorphin, and preproenkephalin mRNA expression in rat striatum depends on activation of NMDA and kainate/AMPA receptors. Brain Res Bull. 1996; 39(6):349-57.
    View in: PubMed
    Score: 0.109
  31. Repeated amphetamine administration induces a prolonged augmentation of phosphorylated cyclase response element-binding protein and Fos-related antigen immunoreactivity in rat striatum. Neuroscience. 1995 Nov; 69(2):441-57.
    View in: PubMed
    Score: 0.108
  32. Cocaine binges differentially alter striatal preprodynorphin and zif/268 mRNAs. Brain Res Mol Brain Res. 1995 Apr; 29(2):201-10.
    View in: PubMed
    Score: 0.103
  33. Forskolin induces preproenkephalin and preprodynorphin mRNA in rat striatum as demonstrated by in situ hybridization histochemistry. Synapse. 1995 Mar; 19(3):151-9.
    View in: PubMed
    Score: 0.103
  34. Role of kainate/AMPA receptors in induction of striatal zif/268 and preprodynorphin mRNA by a single injection of amphetamine. Brain Res Mol Brain Res. 1994 Nov; 27(1):118-26.
    View in: PubMed
    Score: 0.101
  35. Acute amphetamine or methamphetamine alters opioid peptide mRNA expression in rat striatum. Brain Res Mol Brain Res. 1994 Feb; 21(3-4):359-62.
    View in: PubMed
    Score: 0.095
  36. Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum. Neuroreport. 1993 May; 4(5):543-6.
    View in: PubMed
    Score: 0.091
  37. Selective induction of Fos and FRA immunoreactivity within the mesolimbic and mesostriatal dopamine terminal fields. Synapse. 1993 Mar; 13(3):251-63.
    View in: PubMed
    Score: 0.090
  38. RGS4 overexpression in the rat dorsal striatum modulates mGluR5- and amphetamine-mediated behavior and signaling. Psychopharmacology (Berl). 2012 Jun; 221(4):621-35.
    View in: PubMed
    Score: 0.082
  39. Methamphetamine-induced changes in the object recognition memory circuit. Neuropharmacology. 2012 Feb; 62(2):1119-26.
    View in: PubMed
    Score: 0.082
  40. Enhanced dopamine transporter activity in middle-aged Gdnf heterozygous mice. Neurobiol Aging. 2012 Feb; 33(2):427.e1-14.
    View in: PubMed
    Score: 0.077
  41. Direct neurotoxic effects of colchicine on cholinergic neurons in medial septum and striatum. Neurosci Lett. 1988 Nov 22; 94(1-2):46-51.
    View in: PubMed
    Score: 0.067
  42. Lennart Heimer: in memoriam (1930--2007). Brain Struct Funct. 2008 Sep; 213(1-2):3-10.
    View in: PubMed
    Score: 0.065
  43. Long-term consequences of methamphetamine exposure in young adults are exacerbated in glial cell line-derived neurotrophic factor heterozygous mice. J Neurosci. 2007 Aug 15; 27(33):8816-25.
    View in: PubMed
    Score: 0.061
  44. The role of dorsal striatal GABA(A) receptors in dopamine agonist-induced behavior and neuropeptide gene expression. Brain Res. 1999 Jul 31; 836(1-2):99-109.
    View in: PubMed
    Score: 0.035
  45. The full D1 dopamine receptor agonist SKF-82958 induces neuropeptide mRNA in the normosensitive striatum of rats: regulation of D1/D2 interactions by muscarinic receptors. J Pharmacol Exp Ther. 1997 May; 281(2):972-82.
    View in: PubMed
    Score: 0.030
  46. The effects of D1 or D2 dopamine receptor blockade on zif/268 and preprodynorphin gene expression in rat forebrain following a short-term cocaine binge. Brain Res Mol Brain Res. 1996 Jan; 35(1-2):237-48.
    View in: PubMed
    Score: 0.027
  47. Dopamine differentially regulates dynorphin, substance P, and enkephalin expression in striatal neurons: in situ hybridization histochemical analysis. J Neurosci. 1991 Apr; 11(4):1016-31.
    View in: PubMed
    Score: 0.020
  48. Effects of brain-derived neurotrophic factor on dopaminergic function and motor behavior during aging. Genes Brain Behav. 2011 Mar; 10(2):186-98.
    View in: PubMed
    Score: 0.019
  49. High density of zinc-containing and dynorphin B- and substance P-immunoreactive terminals in the marginal division of the rat striatum. Brain Res Bull. 1990 Feb; 24(2):201-5.
    View in: PubMed
    Score: 0.018
  50. Differential modulation of striatonigral dynorphin and enkephalin by dopamine receptor subtypes. Brain Res. 1990 Jan 15; 507(1):57-64.
    View in: PubMed
    Score: 0.018
  51. Lithium increases rat striatal beta- and gamma-preprotachykinin messenger RNAs. J Pharmacol Exp Ther. 1989 Mar; 248(3):1297-301.
    View in: PubMed
    Score: 0.017
  52. Regulation of the metabolism of striatal dynorphin by the dopaminergic system. J Pharmacol Exp Ther. 1988 Jul; 246(1):403-8.
    View in: PubMed
    Score: 0.016
  53. Dopaminergic regulation of tachykinin metabolism in the striatonigral pathway. J Pharmacol Exp Ther. 1987 Nov; 243(2):792-8.
    View in: PubMed
    Score: 0.015
  54. Amygdaloid kindling increases enkephalin-like immunoreactivity but decreases dynorphin-A-like immunoreactivity in rat hippocampus. Neurosci Lett. 1986 Oct 30; 71(1):31-6.
    View in: PubMed
    Score: 0.014
  55. Lithium increases dynorphin A(1-8) and prodynorphin mRNA levels in the basal ganglia of rats. Brain Res. 1988 Apr; 427(2):155-63.
    View in: PubMed
    Score: 0.004
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.